RLAY Relay Therapeutics, Inc. Loading... : Investor Sentiment and Bull/Bear Views

Loading chart...
Top Calls

Price change since each call, adjusted for long/short direction. Results calculated:

Feed
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
All Content✓
Source feeds
Buzzberg Top 50 ✓
All market capsNo capitalization filter✓
200 B and aboveMega✓
10 B to 200 BLarge✓
2 B to 10 BMid✓
0 to 2 BSmall✓
Custom
Enter market cap range in B USD
Time Author Thesis Company / ticker Signal Since call Position Source
23:30
Oct 18
r/wallstreetbets
Holding RLAY, up 150% on cancer pipeline
The author holds Relay Therapeutics and is up roughly 150%, citing its cancer-focused pipeline as the reason. The claim is a personal holding disclosure rather than a detailed forward thesis; no catalyst or timeframe is specified.
RLAY Relay Therapeutics, Inc. Long 1ST Position: Holding —

About RLAY Investor Commentary

Across the available history and selected sources, Buzzberg tracks RLAY (Relay Therapeutics, Inc.) across 2 sources: 1 bullish vs 0 bearish calls from 2 authors. Historical directional balance: 25% = 100 × (bullish − bearish) / all deduplicated idea records, including other directions. This is neither a probability of a price rise nor the share of bullish authors. 4 total trade ideas tracked. Past 7 days, before deduplication: 1 bullish. Latest voices: u/Ok-End-3213.